Published on 19 October 2026
A new audit of prostate cancer shows far fewer men are now dying with the disease compared with 10 years ago.
New figures published by the National Prostate Cancer Audit show that significantly fewer males diagnosed with incurable advanced prostate cancer are dying within three years of diagnosis when compared to a decade ago.
Liverpool doctor Professor Kevin Mortimer, a Respiratory Consultant at Aintree Hospital, is among the growing number of men benefiting from advances in prostate cancer treatment.
Prof Mortimer was preparing to celebrate his daughter’s 11th birthday when he received the devastating news that he had stage four prostate cancer. The diagnosis left him fearing he was experiencing many milestones for the last time. Just two years later, however, specialist treatment at The Clatterbridge Cancer Centre has reduced his cancer to an undetectable level.
After receiving his diagnosis from colleagues at Aintree, Prof Mortimer underwent a combination of chemotherapy, radiotherapy and the hormone therapy darolutamide. The treatment, known as triple therapy, is a relatively new option for eligible patients with advanced prostate cancer and is helping to improve outcomes for many men.
He said: "I’m living proof of how far treatments for prostate cancer have come in the past few years thanks to investment, innovation and cutting-edge science.”
Read more about this here: Treatment breakthroughs helping men with incurable prostate cancer | Prostate Cancer UK